Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BMS-1 (Synonyms: PD1-PDL1 inhibitor 1, PD-1/PD-L1 inhibitor 1)

Catalog No. T3655 Copy Product Info
Purity: 99.81%
😃Good
Hot
BMS-1 (PD-1/PD-L1 inhibitor 1) is an inhibitor of the PD1-PD-L1 protein-protein interaction. It also acts as an immunomodulator. Programmed death ligand 1 (PD-L1) is a protein in humans that is encoded by the CD274 gene and the upregulation of PD-L1 allows Ys to evade the host immune system. High tumor expression of PD-L1 was associated with increased tumor aggressiveness and a 4.5-fold increased risk of death.

BMS-1

Copy Product Info
😃Good
Hot
Catalog No. T3655
Synonyms PD1-PDL1 inhibitor 1, PD-1/PD-L1 inhibitor 1

BMS-1 (PD-1/PD-L1 inhibitor 1) is an inhibitor of the PD1-PD-L1 protein-protein interaction. It also acts as an immunomodulator. Programmed death ligand 1 (PD-L1) is a protein in humans that is encoded by the CD274 gene and the upregulation of PD-L1 allows Ys to evade the host immune system. High tumor expression of PD-L1 was associated with increased tumor aggressiveness and a 4.5-fold increased risk of death.

BMS-1
Cas No. 1675201-83-8
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$34In StockIn Stock
5 mg$77In StockIn Stock
10 mg$115In StockIn Stock
25 mg$219In StockIn Stock
50 mg$328In StockIn Stock
100 mg$496In StockIn Stock
1 mL x 10 mM (in DMSO)$80In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.81%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

BMS-1 AI Summary
BMS-1 exhibits significant bioactivity in various assays. It shows effective inhibition of the PD-1/PD-L1 protein-protein interaction, with IC50 values ranging from 6.0 nM to 91.8 nM in different HTRF assays. In co-culture assays with human PBMC-derived CD3-positive T cells and human Hep3B cells expressing PD-L1, it significantly increases IFNgamma secretion by up to 98.69% at a concentration of 5 uM after 72 hours. The compound also demonstrates antiviral activity against SARS-CoV-2, inhibiting virus-induced cytotoxicity in Caco-2 and VERO-6 cells at 10 uM concentrations after 48 hours. Furthermore, BMS-1 exhibits moderate activity against the human HDAC6 enzyme, with inhibition percentages of 64.23% and 51.31% using different peptide substrates, and it shows cytotoxicity against human Jurkat cells with an IC50 of 18400 nM after 48 hours of incubation. However, its efficacy against SARS-CoV-2 3CL-Pro protease appears to be limited..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
BMS-1 (PD-1/PD-L1 inhibitor 1) is an inhibitor of the PD1-PD-L1 protein-protein interaction. It also acts as an immunomodulator. Programmed death ligand 1 (PD-L1) is a protein in humans that is encoded by the CD274 gene and the upregulation of PD-L1 allows Ys to evade the host immune system. High tumor expression of PD-L1 was associated with increased tumor aggressiveness and a 4.5-fold increased risk of death.
Targets&IC50
PD-1/PD-L1:0.006 μM
SynonymsPD1-PDL1 inhibitor 1, PD-1/PD-L1 inhibitor 1
Chemical Properties
Molecular Weight475.58
FormulaC29H33NO5
Cas No.1675201-83-8
SmilesCOc1cc(OCc2cccc(c2C)-c2ccccc2)cc(OC)c1CN1CCCC[C@H]1C(O)=O
Relative Density.1.182 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 13 mg/mL (27.34 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.1 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1027 mL10.5135 mL21.0270 mL105.1348 mL
5 mM0.4205 mL2.1027 mL4.2054 mL21.0270 mL
10 mM0.2103 mL1.0513 mL2.1027 mL10.5135 mL
20 mM0.1051 mL0.5257 mL1.0513 mL5.2567 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BMS-1 | purchase BMS-1 | BMS-1 cost | order BMS-1 | BMS-1 chemical structure | BMS-1 formula | BMS-1 molecular weight